ScottFeldmanMD

PubMed

• 53BP1 Contributes to Igh Locus Chromatin Topology during Class Switch Recombination.
  Feldman, S.,Wuerffel, R.,Achour, I.,Wang, L.,Carpenter, P. B.,Kenter, A. L.> ;J. Immunol.. 2017 Feb 06
• Long-term adherence to topical psoriasis treatment can be abysmal: a 1-year randomized intervention study using objective electronic adherence monitoring.
  Alinia H, Moradi Tuchayi S, Smith JA, Richardson IM, Bahrami N, Jaros SC, Sandoval LF, Farhangian ME, Anderson KL, Huang KE, Feldman SR> ;Br. J. Dermatol.. 2016-09-24
• Tofacitinib, an oral Janus kinase inhibitor, for the treatment of chronic plaque psoriasis: results from two randomized, placebo-controlled, phase III trials.
  Papp KA, Menter MA, Abe M, Elewski B, Feldman SR, Gottlieb AB, Langley R, Luger T, Thaci D, Buonanno M, Gupta P, Proulx J, Lan S, Wolk R> ;Br. J. Dermatol.. 2015-10-01
• The genetics of pyoderma gangrenosum and implications for treatment: a systematic review.
  DeFilippis EM, Feldman SR, Huang WW> ;Br. J. Dermatol.. 2015-06-01
• The treatment of rosacea with topical ivermectin.
  Ali ST, Alinia H, Feldman SR> ;Drugs Today. 2015-04-01
• Improved psoriasis with weight loss: the role of behavioural factors.
  Sandoval LF, Pierce A, Davis SA, Feldman SR> ;Br. J. Dermatol.. 2015-03-01
• Pharmacological treatments in pregnant women with psoriasis in the U.S.A.
  Lin HC, Hunnicutt JN, Moustafa FA, Rohr AL, Huang KE, Balkrishnan R, Feldman SR> ;Br. J. Dermatol.. 2015-03-01
• Monitoring psoriasis patients being treated with tumour necrosis factor inhibitors: use your judgment.
  Feldman SR> ;Br. J. Dermatol.. 2011-08-01
• Cause-specific mortality in patients with severe psoriasis.
  Feldman SR> ;Br. J. Dermatol.. 2010-09-01
• Using 'number needed to treat' to help conceptualize the magnitude of benefit and risk of tumour necrosis factor-alpha inhibitors for patients with severe psoriasis.
  Dharamsi JW, Bhosle M, Balkrishnan R, Yentzer BA, Feldman SR> ;Br. J. Dermatol.. 2009-09-01
• Economic evaluation of systemic therapies for moderate to severe psoriasis.
  Sizto S, Bansback N, Feldman SR, Willian MK, Anis AH> ;Br. J. Dermatol.. 2009-06-01
• Infliximab improves health-related quality of life in the presence of comorbidities among patients with moderate-to-severe psoriasis.
  Feldman, S. R.,Gottlieb, A. B.,Bala, M.,Wu, Y.,Eisenberg, D.,Guzzo, C.,Li, S.,Dooley, L. T.,Menter, A.> ;Br. J. Dermatol.. 2008 Sep
• Development and validation of the Dermatomyositis Skin Severity Index.
  Carroll CL, Lang W, Snively B, Feldman SR, Callen J, Jorizzo JL> ;Br. J. Dermatol.. 2008-02-01
• Infliximab treatment results in significant improvement in the quality of life of patients with severe psoriasis: a double-blind placebo-controlled trial.
  Feldman SR, Gordon KB, Bala M, Evans R, Li S, Dooley LT, Guzzo C, Patel K, Menter A, Gottlieb AB> ;Br. J. Dermatol.. 2005-05-01
• The Self-Administered Psoriasis Area and Severity Index provides an objective measure of psoriasis severity.
  Feldman SR, Clark AR, Venkat AP, Fleischer AB, Anderson RT, Rajagopalan R> ;Br. J. Dermatol.. 2005-02-01
• Better medication adherence results in greater improvement in severity of psoriasis.
  Carroll CL, Feldman SR, Camacho FT, Balkrishnan R> ;Br. J. Dermatol.. 2004-10-01
• Anger and acne: implications for quality of life, patient satisfaction and clinical care.
  Rapp DA, Brenes GA, Feldman SR, Fleischer AB, Graham GF, Dailey M, Rapp SR> ;Br. J. Dermatol.. 2004-07-01
• Improved health-related quality of life following a randomized controlled trial of alefacept treatment in patients with chronic plaque psoriasis.
  Feldman SR, Menter A, Koo JY> ;Br. J. Dermatol.. 2004-02-01
• Development and validation of a health-related quality of life instrument for women with melasma.
  Balkrishnan R, McMichael AJ, Camacho FT, Saltzberg F, Housman TS, Grummer S, Feldman SR, Chren M> ;Br. J. Dermatol.. 2003-09-01
• Use of the Self-Administered Eczema Area and Severity Index by parent caregivers: results of a validation study.
  Housman TS, Patel MJ, Camacho F, Feldman SR, Fleischer AB, Balkrishnan R> ;Br. J. Dermatol.. 2002-12-01
• Join now to see all